Company: KROS
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001664710-25-000057
Chunk: 0

Company: Keros Therapeutics, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 4, 2025, Keros Therapeutics, Inc. (the “ Company”) held its 2025 Annual Meeting of Stockholders (the “ Annual Meeting”), at which a quorum was present. At the Annual Meeting, the stockholders of the Company voted on the following three proposals: (1) to elect three nominees for director to hold office until the Company’s 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“ Proposal 1”), (2) to ratify the selection by the Audit Committee of the Board of Directors of the Company (the “ Board of Directors”) of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025 (“ Proposal 2”) and (3) to approve, on an advisory basis, the compensation of the Company’s named executive officers (“ Proposal 3”) as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 23, 2025 (the “ Proxy Statement”). Each of Proposal 1, Proposal 2 and Proposal 3 are described in detail in the Proxy Statement. The final results of the voting on each proposal are set forth below.

Proposal 1 - Election of Directors

The Company’s stockholders elected the three persons listed below as directors, each to serve until the Company’s 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The votes cast were as follows:

  Nominee                     Votes For      Votes Withheld      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────────────────
  Mary Ann Gray, Ph. D.      13,703,361          10,006,911             4,297,008  
  Ran Nussbaum               22,703,180           5,304,100             4,297,008  
  Alpna Seth, Ph. D.         15,091,438           8,618,834             4,297,008  

Proposal 2 - Ratification of the Selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Independent Registered Public Accounting Firm of the Company for its Fiscal Year Ending December 31, 2025

The Company’s stockholders approved Proposal 2. The votes cast were as follows: